Form 8-K - Current report:
SEC Accession No. 0001144204-17-004313
Filing Date
2017-01-27
Accepted
2017-01-27 16:16:56
Documents
1
Period of Report
2017-01-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v457781_8k.htm 8-K 14200
  Complete submission text file 0001144204-17-004313.txt   15640
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 17553923
SIC: 2834 Pharmaceutical Preparations